Identification of a core miRNA-pathway regulatory network in glioma by therapeutically targeting miR-181d, miR-21, miR-23b, β-Catenin, CBP, and STAT3.
The application of microRNAs (miRNAs) in the therapeutics of glioma and other human diseases is an area of intense interest. However, it's still a great challenge to interpret the functional consequences of using miRNAs in glioma therapy. Here, we examined paired deep sequencing expression prof...
Main Authors: | Ronghong Li, Xiang Li, Shangwei Ning, Jingrun Ye, Lei Han, Chunsheng Kang, Xia Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4090169?pdf=render |
Similar Items
-
Potential Diagnostic and Prognostic Utility of miR-141, miR-181b1, and miR-23b in Breast Cancer
by: Mohamed Taha, et al.
Published: (2020-11-01) -
Diagnostic Value of Plasma miR-181b, miR-196a, and miR-210 Combination in Pancreatic Cancer
by: Gongpan Liu, et al.
Published: (2020-01-01) -
Identification and Promoter Activity Analysis of Porcine miR-181 and miR-1
by: Hai-xin ZHANG, et al.
Published: (2012-06-01) -
MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients
by: Dorota Jesionek-Kupnicka, et al.
Published: (2017-07-01) -
miR-103/miR-195/miR-15b Regulate SALL4 and Inhibit Proliferation and Migration in Glioma
by: Li-Ping Chen, et al.
Published: (2018-11-01)